DSP Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.3% 1D
NAV on
Fund Summary
Ionic AI
Loading...
Fund Overview
- Rating
3 - Minimum Investment₹100
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹3143 Cr
- Created on5 Nov 2018
Fund Ranking
#14
/ 14 in Sectoral-Pharma
Risk Level
Very High
Returns
Trailing Return
Rolling Return
- 6 Month4.4%
- 1 Year8.6%
- 3 Year (CAGR)22.0%
- All Time (CAGR)20.8%
Category Return
- 6 Month5.7%
- 1 Year10.2%
- 3 Year (CAGR)23.3%
- All Time (CAGR)-
Asset Allocation
- Equity97.6%
- Other2.4%
Top 5 Holdings
Top 5 Sectors
- Aarti Drugs1.02%
- Apollo Hospitals Enterprise4.73%
- Cipla7.56%
- Ipca Laboratories8.26%
- Kovai Medical Center & Hospital2.97%
Fund Information
- Expense Ratio1.92%
- Exit LoadExit load of 0.50% if redeemed within 1 month.
- Lock-In PeriodNo Lock-In
Managed By
Jay Kothari
Nov 2018 - Present
Chirag Dagli
Dec 2020 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.02 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 15.56 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -0.50 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.86